Deep Intelligence Across Industries

Company Headquarters: California, US Founded: 2006 Workforce: 676 employees Company Working: The company was established in 2006 and is a global medical device company focused on providing innovative neuromodulation devices products for the treatment of chronic pain. The company has developed and commercialized the Senza spinal cord stimulation system for the treatment of chronic pain. The company has a presence in North America, Europe, and Australia.

Company Headquarters: Texas, US Founded: 2016 Company Working: Nuvectra Corporation offers its devices for neurological indications such as spinal cord stimulation. Moreover, the company is continuously engaged in improving and developing medical devices for neurological conditions, such as sacral nerve stimulation and deep brain stimulation.

Company Headquarters: Georgia, US Founded: 2013 Workforce: ~400 Company Working: Arbor Pharmaceuticals, LLC (Arbor Pharmaceuticals) is a specialty pharmaceutical company based in the US that researches, develops, manufactures, and commercializes prescription products. The company operates through hospital & specialty, cardiology, neuroscience, pediatrics, and legacy & generics businesses. Gliadel is a registered trademark of Eisai Inc. and is manufactured by Eisai Inc., for Arbor Pharmaceuticals. The company markets various generic prescription products through its Wilshire division and has over a dozen abbreviated new drug applications (ANDAs) on file with the FDA and many others in different stages of development. The company produces novel chemical entities and previously approved molecules for new indications or in improved dosage forms.

Company Headquarters: Wilmington, NC Founded: 1985 Workforce: 21,000 Company Working: Pharmaceutical Product Development, LLC (PPD) is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. The firm’s clients and partners include pharmaceutical, biotechnology, medical device, and academic and government organizations. With offices in 47 countries and approximately 20,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise, and to help clients and partners bend the cost and time curve of drug development to deliver life-changing therapies that improve health.

Company Headquarters: Minneapolis, MN Founded: 1978 Workforce: 2500 Company Working: Pace Analytical Services, LLC (Pace) is an industry leader in sampling and analytical testing. The company provides analytical lab products for testing, staffing, and equipment with an extensive scope of services. Pace’s offers analytical testing and sampling for environmental, life sciences, GMP laboratory, and laboratory operations. The company has 32 environmental laboratories, six laboratory operation locations, four life sciences labs, and 48 service centers across the globe.

Company Headquarters: Bromma, Sweden Founded: 2006 Company Working: Moberg Pharma AB develops patented topical pharmaceuticals for the treatment of common disorders through the use of innovative drug delivery. The company comprises only one area of operation, which is the development and commercialization of medical products. MOB-015 is the next generation of nail fungus treatment and BUPI is a new pain treatment for mouth and throat for cancer patients with oral mucositis. MOB-015 is currently undergoing two parallel phase 3 studies with expected topline results towards the end of 2019 and the second quarter of 2020, respectively. It has also signed two license agreements with leading players in Europe and Canada. It markets its products directly in the US, as well as through a network of distributors in approximately 40 countries.

Company Headquarters: US Founded:1977 Workforce: 200 Company Working: Toxikon is involved in preclinical contract research organization (CRO) for drug and medical device testing. Toxikon provides analytical, in-vivo, and in-vitro testing services for the pharmaceutical, biotechnology, and medical device industry. The services provided by the company include biocompatibility, surgical, ocular models, extractable and leachable (E&L), risk assessments, microbiology, toxicology, chemical characterization, impurities analysis, and synthesis and bioanalytical.

Company Headquarters: Nottingham, Nottinghamshire, UK Founded: 1903 Workforce: 230 Company Working: Source BioScience is a healthcare and biotechnology company that operates businesses in three sectors, namely, healthcare, pharma biotech services, and life science research. The company is engaged in providing diagnostic and screening services to the healthcare sector as well as genetic analyses and biomolecular tools and products to the life science research and pharma biotech sectors. The services offered by Source BioScience in the health care sector comprises screening and reference laboratory diagnostic testing services for cancer and other diseases; whereas for pharma-biotech it offers a range of services from clinical trials, tissue pathology, immunohistochemistry, sophisticated image analysis, biomarker determination, and assay development to pharmacogenomics including genotyping and gene expression analysis.

Company Headquarters: US Founded: 1982 Workforce: 10,001+ Company Working: WuXi AppTec’s laboratory testing division is a comprehensive and integrated testing platform for drug and medical device development. Fully integrated within WuXi AppTec, the laboratory testing division provides in-vivo and in-vitro assays from early screening through clinical sample analysis and medical device testing from development through product lifecycle management. It operates with full transparency, providing the high-quality data needed to advance the project while meeting international standards for regulatory compliance and maintaining industry-leading turnaround times. The laboratory testing division consists of three integrated testing platforms, namely, WuXi AppTec IND (WIND) for preclinical drug development, clinical drug development, and medical device testing. Each platform is supported by the complementary capabilities of four service units, which include analytical, bioanalytical, toxicology, and DMPK services. Testing services are offered as a comprehensive package in support of global IND/NDA filings, or on a standalone basis, with customized study designs available to meet the varying needs of the diverse client base.